| 5.3 |
15.8 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) |
| 2.8 |
8.3 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 2.6 |
2.6 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 2.5 |
7.4 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 2.3 |
7.0 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 2.1 |
12.5 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.9 |
13.4 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 1.8 |
5.3 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 1.8 |
7.1 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 1.7 |
1.7 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 1.6 |
8.2 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 1.5 |
6.1 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 1.5 |
4.4 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 1.4 |
5.8 |
GO:0021586 |
pons maturation(GO:0021586) |
| 1.4 |
5.8 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 1.4 |
4.3 |
GO:1903423 |
positive regulation of synaptic vesicle recycling(GO:1903423) |
| 1.4 |
4.3 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 1.3 |
1.3 |
GO:1900272 |
negative regulation of long-term synaptic potentiation(GO:1900272) |
| 1.3 |
7.9 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 1.3 |
5.2 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 1.3 |
5.0 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 1.2 |
3.7 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 1.2 |
6.0 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 1.2 |
4.6 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 1.2 |
4.6 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 1.1 |
3.4 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.1 |
3.4 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 1.1 |
10.2 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 1.1 |
3.4 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 1.1 |
4.4 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.1 |
3.3 |
GO:0021826 |
substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 1.1 |
3.2 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 1.1 |
3.2 |
GO:2001139 |
negative regulation of postsynaptic membrane organization(GO:1901627) negative regulation of dendritic spine maintenance(GO:1902951) negative regulation of phospholipid efflux(GO:1902999) regulation of lipid transport across blood brain barrier(GO:1903000) negative regulation of lipid transport across blood brain barrier(GO:1903001) positive regulation of lipid transport across blood brain barrier(GO:1903002) negative regulation of phospholipid transport(GO:2001139) |
| 1.1 |
3.2 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 1.1 |
5.3 |
GO:0038093 |
Fc receptor signaling pathway(GO:0038093) |
| 1.1 |
3.2 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 1.1 |
3.2 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 1.0 |
3.1 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 1.0 |
3.1 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 1.0 |
11.3 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 1.0 |
5.1 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 1.0 |
3.0 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 1.0 |
12.0 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.0 |
1.0 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.0 |
1.0 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 1.0 |
2.9 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) |
| 1.0 |
1.0 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 1.0 |
3.9 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 1.0 |
4.8 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.9 |
2.8 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.9 |
7.2 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.9 |
3.6 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.9 |
1.8 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.9 |
29.0 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.9 |
5.2 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.9 |
0.9 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.9 |
5.1 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.9 |
0.9 |
GO:0086011 |
membrane repolarization during action potential(GO:0086011) |
| 0.8 |
16.1 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.8 |
5.9 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.8 |
3.3 |
GO:0006145 |
purine nucleobase catabolic process(GO:0006145) |
| 0.8 |
5.0 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.8 |
0.8 |
GO:2000830 |
vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.8 |
12.8 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.8 |
1.6 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.8 |
11.0 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.8 |
7.1 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.8 |
7.1 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.8 |
1.6 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.8 |
2.3 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 0.7 |
2.2 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.7 |
11.9 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.7 |
3.0 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.7 |
1.5 |
GO:0051464 |
positive regulation of cortisol secretion(GO:0051464) |
| 0.7 |
2.9 |
GO:2000551 |
regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.7 |
2.9 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.7 |
3.6 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.7 |
2.1 |
GO:0046959 |
habituation(GO:0046959) |
| 0.7 |
4.8 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.7 |
2.8 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.7 |
2.1 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.7 |
4.1 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.7 |
3.4 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.7 |
1.3 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.7 |
2.7 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 0.7 |
3.3 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.7 |
2.0 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.7 |
2.6 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.6 |
4.5 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.6 |
0.6 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.6 |
4.5 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.6 |
1.3 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
| 0.6 |
3.1 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.6 |
1.9 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.6 |
1.9 |
GO:0010511 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.6 |
5.6 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.6 |
1.2 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.6 |
3.0 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.6 |
1.8 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 0.6 |
1.2 |
GO:0098911 |
regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
| 0.6 |
4.2 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.6 |
1.2 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.6 |
4.1 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
| 0.6 |
2.3 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.6 |
1.8 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 0.6 |
2.3 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.6 |
5.8 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.6 |
1.7 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.6 |
0.6 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.6 |
1.7 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.6 |
1.7 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.6 |
2.8 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.6 |
1.7 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.6 |
1.1 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.6 |
2.2 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.5 |
1.6 |
GO:0045869 |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.5 |
1.6 |
GO:0032499 |
detection of peptidoglycan(GO:0032499) |
| 0.5 |
10.4 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.5 |
1.6 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.5 |
2.7 |
GO:2001025 |
positive regulation of response to drug(GO:2001025) |
| 0.5 |
4.8 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.5 |
1.1 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.5 |
5.3 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.5 |
1.6 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.5 |
5.2 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.5 |
5.8 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.5 |
1.6 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.5 |
1.0 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.5 |
2.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.5 |
0.5 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.5 |
4.6 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.5 |
0.5 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.5 |
0.5 |
GO:0060620 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.5 |
0.5 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.5 |
0.5 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.5 |
6.0 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.5 |
0.5 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.5 |
3.0 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.5 |
0.5 |
GO:2000277 |
positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
| 0.5 |
1.5 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.5 |
2.9 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.5 |
6.8 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.5 |
2.4 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.5 |
1.9 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.5 |
2.9 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.5 |
3.3 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.5 |
0.5 |
GO:2000662 |
interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
| 0.5 |
1.9 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.5 |
13.5 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.5 |
5.1 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.5 |
1.4 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.5 |
5.6 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.5 |
7.8 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.5 |
10.1 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.5 |
1.8 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.4 |
2.2 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.4 |
7.1 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.4 |
0.9 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.4 |
0.4 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.4 |
1.3 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 0.4 |
3.1 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.4 |
1.7 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.4 |
0.9 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.4 |
0.9 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.4 |
2.2 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.4 |
2.6 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.4 |
1.7 |
GO:0010919 |
regulation of inositol phosphate biosynthetic process(GO:0010919) |
| 0.4 |
2.5 |
GO:0097324 |
melanocyte migration(GO:0097324) |
| 0.4 |
2.1 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.4 |
2.1 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.4 |
0.4 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.4 |
2.9 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.4 |
0.4 |
GO:0032489 |
regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.4 |
4.5 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.4 |
2.4 |
GO:0006172 |
ADP biosynthetic process(GO:0006172) |
| 0.4 |
1.2 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.4 |
1.6 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.4 |
0.4 |
GO:0022028 |
tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
| 0.4 |
0.8 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.4 |
2.0 |
GO:0014832 |
urinary bladder smooth muscle contraction(GO:0014832) |
| 0.4 |
0.4 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 0.4 |
1.6 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.4 |
1.2 |
GO:1901894 |
regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.4 |
2.8 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.4 |
2.0 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.4 |
1.2 |
GO:0043465 |
regulation of fermentation(GO:0043465) negative regulation of fermentation(GO:1901003) |
| 0.4 |
0.8 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) regulation of hydrogen peroxide biosynthetic process(GO:0010728) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.4 |
2.7 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.4 |
1.9 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.4 |
0.8 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.4 |
3.9 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.4 |
3.1 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.4 |
1.9 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.4 |
0.4 |
GO:0032803 |
low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.4 |
1.1 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 0.4 |
1.5 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.4 |
0.4 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.4 |
3.4 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.4 |
1.5 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.4 |
1.5 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.4 |
1.9 |
GO:0021636 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
| 0.4 |
0.4 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.4 |
3.4 |
GO:0071435 |
potassium ion export(GO:0071435) |
| 0.4 |
1.5 |
GO:0070942 |
neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) |
| 0.4 |
4.4 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.4 |
3.7 |
GO:0090331 |
negative regulation of platelet aggregation(GO:0090331) |
| 0.4 |
4.8 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.4 |
0.7 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.4 |
1.5 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.4 |
0.4 |
GO:0045346 |
regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.4 |
0.4 |
GO:0045342 |
MHC class II biosynthetic process(GO:0045342) |
| 0.4 |
1.4 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.4 |
2.1 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.4 |
1.1 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.4 |
0.7 |
GO:0072008 |
glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 0.4 |
1.8 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.4 |
1.1 |
GO:0039521 |
suppression by virus of host autophagy(GO:0039521) negative regulation of sphingolipid biosynthesis involved in cellular sphingolipid homeostasis(GO:0090157) |
| 0.4 |
1.4 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.3 |
0.3 |
GO:0051238 |
sequestering of metal ion(GO:0051238) |
| 0.3 |
1.7 |
GO:0098927 |
vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.3 |
1.0 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.3 |
3.1 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.3 |
2.7 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.3 |
1.4 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.3 |
1.0 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.3 |
0.7 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.3 |
3.4 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.3 |
1.0 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.3 |
2.4 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.3 |
2.3 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.3 |
0.7 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.3 |
2.7 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.3 |
2.0 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.3 |
7.6 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.3 |
1.0 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.3 |
6.3 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.3 |
2.3 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.3 |
1.0 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.3 |
1.0 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.3 |
6.5 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.3 |
1.0 |
GO:0060912 |
cardiac cell fate specification(GO:0060912) |
| 0.3 |
1.3 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.3 |
1.0 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.3 |
0.3 |
GO:0060789 |
hair follicle placode formation(GO:0060789) |
| 0.3 |
6.1 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.3 |
0.3 |
GO:0002604 |
dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
| 0.3 |
1.0 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.3 |
0.6 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.3 |
11.1 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.3 |
1.3 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.3 |
1.3 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.3 |
3.5 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.3 |
0.3 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.3 |
1.3 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.3 |
0.6 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.3 |
6.8 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.3 |
0.9 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.3 |
10.2 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.3 |
1.5 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.3 |
1.8 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
| 0.3 |
0.3 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.3 |
0.3 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.3 |
0.6 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.3 |
0.9 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.3 |
0.6 |
GO:0051797 |
regulation of hair follicle development(GO:0051797) |
| 0.3 |
0.9 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.3 |
0.3 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.3 |
0.9 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.3 |
1.5 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.3 |
1.2 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.3 |
0.9 |
GO:0009193 |
pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) UDP metabolic process(GO:0046048) |
| 0.3 |
2.4 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.3 |
3.9 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.3 |
2.1 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.3 |
2.1 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.3 |
2.7 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.3 |
0.3 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.3 |
2.1 |
GO:0021540 |
corpus callosum morphogenesis(GO:0021540) |
| 0.3 |
1.2 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.3 |
0.3 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.3 |
3.8 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.3 |
0.3 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.3 |
1.7 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.3 |
0.9 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.3 |
0.3 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.3 |
11.5 |
GO:0032355 |
response to estradiol(GO:0032355) |
| 0.3 |
1.4 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.3 |
0.9 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.3 |
1.1 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.3 |
0.6 |
GO:0071285 |
response to lithium ion(GO:0010226) cellular response to lithium ion(GO:0071285) |
| 0.3 |
2.8 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.3 |
0.3 |
GO:0071220 |
response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.3 |
0.8 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.3 |
1.7 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.3 |
0.8 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.3 |
1.1 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.3 |
1.7 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.3 |
0.3 |
GO:0032237 |
activation of store-operated calcium channel activity(GO:0032237) |
| 0.3 |
1.1 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.3 |
6.5 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.3 |
1.4 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.3 |
0.3 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.3 |
8.4 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.3 |
1.3 |
GO:0006598 |
polyamine catabolic process(GO:0006598) spermine catabolic process(GO:0046208) |
| 0.3 |
4.0 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.3 |
1.3 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.3 |
2.7 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.3 |
1.3 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) |
| 0.3 |
1.9 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.3 |
0.5 |
GO:2000347 |
positive regulation of hepatocyte proliferation(GO:2000347) |
| 0.3 |
1.1 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.3 |
0.3 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.3 |
0.8 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.3 |
1.1 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.3 |
0.5 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.3 |
1.6 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.3 |
0.8 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.3 |
1.0 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.3 |
0.5 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.3 |
7.0 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.3 |
1.0 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.3 |
0.8 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.3 |
0.5 |
GO:1902837 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) amino acid import into cell(GO:1902837) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
| 0.3 |
1.5 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.3 |
2.0 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 |
0.5 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.3 |
0.5 |
GO:1903273 |
regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.3 |
0.5 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.3 |
2.5 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.3 |
0.5 |
GO:0051646 |
mitochondrion localization(GO:0051646) |
| 0.2 |
2.5 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 |
3.7 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.2 |
2.2 |
GO:0045061 |
thymic T cell selection(GO:0045061) |
| 0.2 |
3.4 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.2 |
0.2 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.2 |
1.2 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.2 |
1.2 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.2 |
1.4 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.2 |
1.9 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.2 |
2.6 |
GO:0010748 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.2 |
1.2 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.2 |
0.2 |
GO:0042939 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.2 |
0.5 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.2 |
0.7 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.2 |
0.5 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.2 |
1.9 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.2 |
0.7 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.2 |
0.9 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.2 |
2.3 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.2 |
1.4 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.2 |
5.9 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.2 |
1.6 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.2 |
5.4 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.2 |
0.7 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.2 |
0.9 |
GO:0002692 |
negative regulation of cellular extravasation(GO:0002692) |
| 0.2 |
0.4 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.2 |
0.2 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.2 |
2.9 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.2 |
0.4 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.2 |
0.4 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.2 |
2.9 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.2 |
1.3 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.2 |
1.8 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.2 |
0.2 |
GO:0048550 |
negative regulation of pinocytosis(GO:0048550) |
| 0.2 |
1.3 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.2 |
0.7 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.2 |
0.4 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.2 |
0.6 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 0.2 |
1.7 |
GO:0050687 |
negative regulation of defense response to virus(GO:0050687) |
| 0.2 |
0.6 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 |
0.6 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.2 |
2.1 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.2 |
3.6 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.2 |
0.4 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.2 |
1.4 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.2 |
10.3 |
GO:1901379 |
regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.2 |
3.3 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.2 |
0.2 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.2 |
0.8 |
GO:0015824 |
proline transport(GO:0015824) |
| 0.2 |
0.4 |
GO:0033632 |
regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.2 |
0.6 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.2 |
0.4 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.2 |
0.2 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.2 |
7.7 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 |
4.4 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.2 |
0.6 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.2 |
0.6 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.2 |
0.6 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 |
2.6 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.2 |
2.6 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
| 0.2 |
1.0 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.2 |
0.8 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.2 |
1.0 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.2 |
2.4 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.2 |
1.0 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 0.2 |
0.4 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) |
| 0.2 |
0.8 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.2 |
1.0 |
GO:0033005 |
positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.2 |
0.4 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.2 |
2.9 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.2 |
0.2 |
GO:2000858 |
mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) positive regulation of corticosteroid hormone secretion(GO:2000848) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
| 0.2 |
0.6 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.2 |
1.1 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.2 |
0.8 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.2 |
0.8 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.2 |
0.2 |
GO:1903726 |
negative regulation of phospholipid metabolic process(GO:1903726) |
| 0.2 |
1.3 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.2 |
0.6 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.2 |
2.2 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.2 |
3.2 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.2 |
0.6 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.2 |
0.6 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.2 |
0.4 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.2 |
0.2 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.2 |
1.7 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.2 |
1.6 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.2 |
0.2 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) |
| 0.2 |
0.7 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.2 |
0.9 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.2 |
1.3 |
GO:1904667 |
negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.2 |
0.7 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.2 |
0.4 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.2 |
12.4 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.2 |
0.4 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.2 |
0.5 |
GO:0050849 |
negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.2 |
0.4 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.2 |
0.9 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 |
1.6 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 |
0.9 |
GO:0010310 |
regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.2 |
1.9 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.2 |
2.1 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.2 |
0.7 |
GO:0014889 |
muscle atrophy(GO:0014889) |
| 0.2 |
2.5 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.2 |
0.5 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.2 |
1.6 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 |
1.4 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.2 |
0.2 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
1.2 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 |
0.5 |
GO:0001777 |
T cell homeostatic proliferation(GO:0001777) |
| 0.2 |
0.7 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.2 |
0.5 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.2 |
1.5 |
GO:0010543 |
regulation of platelet activation(GO:0010543) |
| 0.2 |
1.5 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.2 |
0.7 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
| 0.2 |
0.5 |
GO:0015840 |
urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
| 0.2 |
0.2 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.2 |
1.0 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.2 |
1.2 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.2 |
0.5 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.2 |
1.3 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.2 |
1.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.2 |
0.5 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.2 |
0.8 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.2 |
0.8 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.2 |
0.7 |
GO:0050806 |
positive regulation of synaptic transmission(GO:0050806) |
| 0.2 |
1.3 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.2 |
0.5 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.2 |
0.8 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.2 |
1.1 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 |
0.8 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.2 |
0.3 |
GO:0019530 |
taurine metabolic process(GO:0019530) |
| 0.2 |
3.4 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.2 |
0.6 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 |
0.6 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.2 |
1.6 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.2 |
1.2 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.2 |
0.5 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.2 |
0.3 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.2 |
0.3 |
GO:0034351 |
regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.2 |
0.8 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.2 |
0.5 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.2 |
0.9 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
| 0.2 |
0.2 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.2 |
0.6 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.2 |
1.1 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.1 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.1 |
1.5 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 |
1.6 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
0.1 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.1 |
2.2 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.4 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.1 |
0.4 |
GO:1904526 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
| 0.1 |
0.9 |
GO:0097178 |
ruffle assembly(GO:0097178) |
| 0.1 |
1.3 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
1.0 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.1 |
0.9 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
2.4 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.1 |
0.7 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.1 |
0.3 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.1 |
0.3 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.1 |
3.2 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.1 |
0.7 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 |
0.7 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.1 |
0.6 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.3 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.1 |
0.6 |
GO:0072578 |
neurotransmitter-gated ion channel clustering(GO:0072578) |
| 0.1 |
2.1 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
0.3 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.1 |
1.5 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.1 |
1.3 |
GO:0045010 |
actin nucleation(GO:0045010) |
| 0.1 |
0.8 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
0.5 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.1 |
0.3 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.1 |
0.8 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.1 |
GO:0010666 |
positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 |
2.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
0.5 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.1 |
0.4 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.1 |
0.5 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
0.3 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.9 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.1 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.1 |
0.4 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
| 0.1 |
1.0 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
0.4 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.1 |
0.8 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.9 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.1 |
0.6 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.5 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 |
2.6 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.1 |
0.5 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
0.3 |
GO:0060913 |
cardiac cell fate determination(GO:0060913) regulation of cardiac cell fate specification(GO:2000043) |
| 0.1 |
1.8 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.1 |
0.3 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
0.3 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.1 |
0.9 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
2.6 |
GO:0031103 |
axon regeneration(GO:0031103) |
| 0.1 |
0.7 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 |
0.2 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.1 |
0.2 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.1 |
0.6 |
GO:1901679 |
nucleotide transmembrane transport(GO:1901679) |
| 0.1 |
1.1 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 |
1.1 |
GO:0015684 |
ferrous iron transport(GO:0015684) |
| 0.1 |
0.2 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.1 |
0.2 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 |
0.5 |
GO:0023035 |
CD40 signaling pathway(GO:0023035) |
| 0.1 |
0.2 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.1 |
0.2 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.1 |
1.8 |
GO:0006047 |
UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.1 |
1.9 |
GO:0015992 |
proton transport(GO:0015992) |
| 0.1 |
0.2 |
GO:0038089 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.1 |
0.4 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.1 |
0.8 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.1 |
1.5 |
GO:0046856 |
phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
0.2 |
GO:0060586 |
multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.1 |
0.2 |
GO:2001140 |
regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
| 0.1 |
1.6 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.1 |
1.3 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
0.5 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
4.2 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
0.6 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) |
| 0.1 |
0.2 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.1 |
1.3 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
0.3 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.1 |
0.5 |
GO:0061622 |
glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.1 |
4.2 |
GO:1902284 |
axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.1 |
1.5 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
1.8 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.1 |
0.9 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.1 |
0.3 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
1.1 |
GO:0001765 |
membrane raft assembly(GO:0001765) |
| 0.1 |
0.3 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
0.5 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.1 |
1.8 |
GO:0006266 |
DNA ligation(GO:0006266) |
| 0.1 |
0.2 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.3 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 |
1.6 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.3 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.1 |
0.2 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.7 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
0.2 |
GO:0071451 |
cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.1 |
0.3 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 |
0.2 |
GO:0071455 |
cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
| 0.1 |
1.1 |
GO:0001783 |
B cell apoptotic process(GO:0001783) |
| 0.1 |
1.0 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
0.4 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.1 |
1.1 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.1 |
0.1 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
0.6 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.1 |
0.6 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 |
0.6 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.1 |
1.0 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
3.1 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.1 |
1.1 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.1 |
0.1 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.1 |
0.4 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
0.3 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.1 |
0.2 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.1 |
1.4 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
0.1 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.1 |
0.6 |
GO:0001963 |
synaptic transmission, dopaminergic(GO:0001963) |
| 0.1 |
0.3 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.1 |
2.1 |
GO:0097576 |
vacuole fusion(GO:0097576) |
| 0.1 |
0.7 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
0.7 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
0.5 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.1 |
1.2 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
1.0 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 |
0.7 |
GO:0042742 |
defense response to bacterium(GO:0042742) |
| 0.1 |
0.2 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 0.1 |
0.3 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
2.2 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 |
0.3 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 |
0.9 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.1 |
1.2 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.1 |
1.1 |
GO:0001964 |
startle response(GO:0001964) |
| 0.1 |
1.1 |
GO:0061050 |
regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
| 0.1 |
0.6 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 |
0.3 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.1 |
0.3 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
0.5 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.1 |
0.2 |
GO:0042159 |
lipoprotein catabolic process(GO:0042159) |
| 0.1 |
0.2 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 |
0.2 |
GO:2001180 |
regulation of interleukin-18 production(GO:0032661) negative regulation of interleukin-18 production(GO:0032701) negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.1 |
0.4 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
0.2 |
GO:0043206 |
extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
| 0.1 |
1.4 |
GO:0071357 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.1 |
0.6 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
0.4 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.1 |
0.4 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.1 |
0.2 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
0.4 |
GO:0043030 |
regulation of macrophage activation(GO:0043030) |
| 0.1 |
0.7 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.9 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.2 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.1 |
2.9 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.1 |
1.3 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.1 |
1.5 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.1 |
0.7 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.1 |
0.4 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
0.2 |
GO:0042268 |
regulation of cytolysis(GO:0042268) |
| 0.1 |
0.2 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.1 |
0.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.3 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 |
1.6 |
GO:0050805 |
negative regulation of synaptic transmission(GO:0050805) |
| 0.1 |
0.2 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.1 |
0.4 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
1.5 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
1.1 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 |
0.3 |
GO:0021730 |
trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
| 0.1 |
3.0 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.1 |
0.2 |
GO:0010889 |
regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) sequestering of triglyceride(GO:0030730) |
| 0.1 |
0.5 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
0.1 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
| 0.1 |
0.3 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 |
0.3 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
0.4 |
GO:1902993 |
positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.1 |
0.5 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
0.2 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 |
0.1 |
GO:0071236 |
cellular response to antibiotic(GO:0071236) |
| 0.1 |
0.5 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.1 |
0.1 |
GO:2000726 |
negative regulation of cardiac muscle cell differentiation(GO:2000726) |
| 0.1 |
1.2 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 |
0.4 |
GO:0002579 |
positive regulation of antigen processing and presentation(GO:0002579) |
| 0.1 |
0.1 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.1 |
1.5 |
GO:0002548 |
monocyte chemotaxis(GO:0002548) |
| 0.1 |
0.3 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.1 |
1.3 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
0.6 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.1 |
0.1 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 |
2.7 |
GO:0010812 |
negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.1 |
0.4 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
1.3 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.1 |
0.1 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.1 |
0.1 |
GO:0061724 |
lipophagy(GO:0061724) |
| 0.1 |
0.3 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 |
0.2 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.1 |
4.3 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.1 |
0.3 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.1 |
1.1 |
GO:0051125 |
regulation of actin nucleation(GO:0051125) |
| 0.1 |
0.2 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
1.1 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.1 |
0.1 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.1 |
0.3 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.4 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.1 |
0.2 |
GO:2000620 |
positive regulation of histone H4 acetylation(GO:0090240) positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.1 |
0.2 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 |
0.3 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.1 |
0.1 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.1 |
0.4 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
0.1 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 0.1 |
0.3 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.1 |
0.1 |
GO:1904008 |
response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.1 |
0.8 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 |
0.1 |
GO:0072034 |
renal vesicle induction(GO:0072034) |
| 0.1 |
0.2 |
GO:0090335 |
regulation of brown fat cell differentiation(GO:0090335) |
| 0.1 |
0.3 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.1 |
0.1 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.1 |
0.3 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.1 |
0.4 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.1 |
0.1 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
0.2 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.3 |
GO:0051503 |
adenine nucleotide transport(GO:0051503) |
| 0.1 |
0.5 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 |
0.1 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.1 |
0.4 |
GO:0071549 |
response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
| 0.1 |
0.6 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
1.2 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.1 |
0.8 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.2 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.1 |
0.2 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.1 |
0.1 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.1 |
0.2 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
2.8 |
GO:0006892 |
post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.1 |
0.1 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.1 |
0.2 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
0.1 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 |
1.8 |
GO:0071804 |
cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.1 |
0.5 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.2 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.1 |
0.5 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.1 |
3.6 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.1 |
0.4 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 |
0.4 |
GO:0015884 |
folic acid transport(GO:0015884) methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.1 |
0.2 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.1 |
0.2 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
0.2 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.2 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.1 |
0.2 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.1 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.1 |
0.4 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 |
1.0 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
3.2 |
GO:0036503 |
ERAD pathway(GO:0036503) |
| 0.1 |
0.2 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.1 |
0.1 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.1 |
0.4 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.2 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.1 |
0.2 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.1 |
0.1 |
GO:1901203 |
positive regulation of extracellular matrix assembly(GO:1901203) |
| 0.1 |
0.5 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.1 |
0.3 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 |
0.1 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 |
0.4 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.1 |
0.1 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.1 |
0.2 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.1 |
0.5 |
GO:1900364 |
negative regulation of mRNA 3'-end processing(GO:0031441) negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 |
0.2 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.1 |
0.2 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 |
0.0 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.0 |
1.2 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.0 |
0.0 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.0 |
0.8 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.0 |
0.1 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.0 |
0.8 |
GO:0090181 |
regulation of cholesterol metabolic process(GO:0090181) |
| 0.0 |
0.6 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.0 |
0.1 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.0 |
0.5 |
GO:0046036 |
GTP biosynthetic process(GO:0006183) CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.0 |
2.3 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.3 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.0 |
0.5 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.3 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.0 |
0.4 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 |
0.6 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.0 |
1.0 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.0 |
0.5 |
GO:0035249 |
synaptic transmission, glutamatergic(GO:0035249) |
| 0.0 |
0.1 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.0 |
0.0 |
GO:2000778 |
positive regulation of interleukin-6 secretion(GO:2000778) |
| 0.0 |
0.3 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 |
0.1 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
0.5 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.0 |
0.1 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.0 |
0.1 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.0 |
0.4 |
GO:0006497 |
protein lipidation(GO:0006497) |
| 0.0 |
0.2 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.0 |
0.3 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
1.1 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
1.3 |
GO:0046488 |
phosphatidylinositol metabolic process(GO:0046488) |
| 0.0 |
0.2 |
GO:0071267 |
amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
| 0.0 |
0.6 |
GO:1901984 |
negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
| 0.0 |
0.2 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
0.4 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.0 |
0.1 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.0 |
0.5 |
GO:0010324 |
membrane invagination(GO:0010324) |
| 0.0 |
0.2 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
| 0.0 |
0.2 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.0 |
0.1 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.0 |
1.0 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.0 |
0.2 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.0 |
0.4 |
GO:0017158 |
regulation of calcium ion-dependent exocytosis(GO:0017158) |
| 0.0 |
0.1 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.0 |
0.2 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.0 |
0.1 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 |
4.0 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.0 |
0.5 |
GO:0009437 |
amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
| 0.0 |
0.4 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.1 |
GO:0035966 |
response to topologically incorrect protein(GO:0035966) |
| 0.0 |
0.1 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 |
0.3 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.0 |
0.1 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.0 |
0.2 |
GO:0043174 |
nucleoside salvage(GO:0043174) |
| 0.0 |
0.1 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.0 |
0.2 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
0.3 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.3 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.0 |
0.3 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.1 |
GO:0010712 |
regulation of collagen metabolic process(GO:0010712) |
| 0.0 |
0.2 |
GO:0035336 |
long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
| 0.0 |
0.2 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.0 |
1.0 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 |
0.1 |
GO:0007128 |
meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.0 |
0.1 |
GO:0034139 |
regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
| 0.0 |
0.1 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.0 |
0.1 |
GO:0048241 |
epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
| 0.0 |
0.2 |
GO:0010561 |
negative regulation of glycoprotein biosynthetic process(GO:0010561) |
| 0.0 |
0.1 |
GO:0042157 |
lipoprotein metabolic process(GO:0042157) |
| 0.0 |
0.1 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.0 |
0.2 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.0 |
0.1 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
1.3 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.0 |
0.2 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.0 |
3.8 |
GO:0008654 |
phospholipid biosynthetic process(GO:0008654) |
| 0.0 |
0.2 |
GO:1990564 |
protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 |
0.0 |
GO:0097066 |
response to thyroid hormone(GO:0097066) |
| 0.0 |
0.2 |
GO:0002192 |
IRES-dependent translational initiation(GO:0002192) |
| 0.0 |
0.3 |
GO:0060914 |
heart formation(GO:0060914) |
| 0.0 |
0.1 |
GO:0009133 |
nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.0 |
0.6 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.0 |
0.2 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 |
0.4 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
| 0.0 |
0.1 |
GO:0002861 |
regulation of inflammatory response to antigenic stimulus(GO:0002861) |
| 0.0 |
0.1 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.0 |
0.5 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.1 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.0 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.0 |
0.7 |
GO:0030166 |
proteoglycan biosynthetic process(GO:0030166) |
| 0.0 |
0.1 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.0 |
0.2 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.0 |
0.2 |
GO:0000479 |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.0 |
0.2 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.0 |
0.1 |
GO:0006563 |
L-serine metabolic process(GO:0006563) |
| 0.0 |
0.1 |
GO:0034340 |
response to type I interferon(GO:0034340) |
| 0.0 |
0.4 |
GO:1902653 |
cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.0 |
0.3 |
GO:2000181 |
negative regulation of blood vessel morphogenesis(GO:2000181) |
| 0.0 |
0.3 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.1 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.0 |
0.4 |
GO:0030811 |
regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |
| 0.0 |
0.1 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.0 |
0.1 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.0 |
1.3 |
GO:0030308 |
negative regulation of cell growth(GO:0030308) |
| 0.0 |
0.2 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 |
0.4 |
GO:0030641 |
regulation of cellular pH(GO:0030641) |
| 0.0 |
0.0 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.0 |
0.1 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.1 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.0 |
0.1 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
| 0.0 |
0.1 |
GO:0042182 |
ketone catabolic process(GO:0042182) |
| 0.0 |
0.1 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.0 |
0.1 |
GO:0035411 |
catenin import into nucleus(GO:0035411) regulation of catenin import into nucleus(GO:0035412) |
| 0.0 |
0.1 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.1 |
GO:0031397 |
negative regulation of protein ubiquitination(GO:0031397) |
| 0.0 |
0.1 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.0 |
0.2 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.0 |
0.0 |
GO:0050926 |
regulation of positive chemotaxis(GO:0050926) positive regulation of positive chemotaxis(GO:0050927) |
| 0.0 |
0.1 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.3 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.0 |
0.0 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.0 |
0.0 |
GO:0051350 |
negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
| 0.0 |
0.0 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.0 |
0.1 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.1 |
GO:0017157 |
regulation of exocytosis(GO:0017157) |
| 0.0 |
0.1 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.0 |
0.1 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 |
0.0 |
GO:2000010 |
regulation of protein localization to cell surface(GO:2000008) positive regulation of protein localization to cell surface(GO:2000010) |
| 0.0 |
0.2 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.0 |
0.1 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.1 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.0 |
0.1 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
0.0 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.0 |
0.0 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.3 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.2 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.0 |
0.1 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.0 |
0.1 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.0 |
0.0 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.0 |
0.1 |
GO:0032402 |
melanosome transport(GO:0032402) |
| 0.0 |
0.1 |
GO:0032988 |
ribonucleoprotein complex disassembly(GO:0032988) |
| 0.0 |
0.2 |
GO:1905037 |
autophagosome organization(GO:1905037) |
| 0.0 |
0.1 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.0 |
0.1 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 |
0.0 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
